PPIPT00202
Target Protein Information
| Protein_Name | Polyubiquitin-B |
|---|---|
| Protein_Sequence | MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGC |
| Organism_Source | Homo sapiens |
| Functional_Classification | Ubiquitin |
| Cellular_Localization | Cytoplasm |
| Gene_Names | UBB |
| UniProt_ID | P0CG47 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | Ub2ii |
|---|---|
| Peptide_Sequence | WWYDREYYYLGYGCG |
| Peptide_Length | 15 |
| Peptide_SMILES | CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)O |
| Chemical_Modification | None |
| Cyclization_Method | Main chain-side chain cyclization; W1<->C15; other bond |
| Linear/Cyclic | Linear |
| N-terminal_Modification | Chloroacetyl |
| C-terminal_Modification | Free |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 1994.17 |
|---|---|
| Aliphatic_Index | 26.00000 |
| Aromaticity | 0.46667 |
| Average_Rotatable_Bonds | 3.66667 |
| Charge_at_pH_7 | -1.06602 |
| Isoelectric_point | 4.18437 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 25 |
| Number_of_Hydrogen_Bond_Donors | 29 |
| Topological_Polar_Surface_Area | 739.95000 |
| X_logP_energy | -1.15213 |
Interaction Information
| Affinity | KD=33 nM |
|---|---|
| Affinity_Assay | Surface Plasmon Resonance |
| PDB_ID | None |
| Type | Inhibitor |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | UBIQUITIN HIGH AFFINITY CYCLIC PEPTIDES AND METHODS OF USE THEREOF |
| Release_Year | 2021 |
| Patent_ID | US20210238231A1 |